The following Hub resources may be available to support innovators' research. Please contact MN-REACH directly for additional information.
MN-REACH Resources
Institute for Engineering in Medicine (IEM) is an interdisciplinary research institute that facilitates collaborations between engineering faculty and biomedical faculty at the UMN and industry. IEM members include 150 faculty members from 31 departments in engineering, medical and health related schools. |
Medical Device Center (MDC) is an interdisciplinary program that sits within the IEM and combines basic research, applied and translational research, education and training, and outreach and public engagement all related to medical devices. |
Institute for Therapeutics Discovery and Development (ITDD) is a drug discovery and development center consisting of five scientific cores (Medicinal Chemistry, High-Throughput Screening, Lead and Probe Discovery, Pharmacology and Biomarkers, and Therapeutics Process Development). |
The Center for Translational Medicine (CTM) facilitates the development of drugs, biologics and devices by providing access to expertise, resources and services, including technology evaluation and development planning, laboratory testing (in vitro through IND/IDE-enabling studies), regulatory support and program management. |
Molecular and Cellular Therapeutics (MCT) facility is a state-of-the-art current good manufacturing practices (cGMP) facility located on UMN campus. MCT has scale up, production assistance, cell manufacture, and related functions. |
The Center for Translational Drug Delivery (CTDD) assists with all aspects of drug delivery and complex development challenges. Its services include pre-formulation, formulation development, preclinical biological testing and analytical services. |
The Center for Orphan Drug Research (CODR) focuses on Orphan Drugs and current research is on rare pediatric neurological disorders. |
The Mill City Innovation Collaboration Center (ICC) provides a real-world venue for evaluating system integration and effectiveness of technologies in ambulatory clinical care, assisted care, and home settings. Building on UMN expertise in practice-based research, the ICC provides simulated environments, community engagement, and access to the clinical settings that deliver most US health care. |
Production Assistance for Cellular Therapy (PACT) is an NHLBI-sponsored program designed to develop novel cellular therapies that will aid investigators by providing production assistance for the scale-up of a product that is intended for use in IND human clinical trials. |
Medical Industry Leadership Institute (MILI) at the Carlson School of Management gives MBA students opportunities to prepare for leadership-track careers in functional areas of the medical industry including finance, marketing, consulting, operations, and information technology. |
Last Updated October 2015